Elsbernd Brian

Chief Compliance/Legal OfficerCATALYST PHARMACEUTICALS, INC. (CPRX) · full profile →Form 4 · filed Nov 14, 2025
Net Buying
Open-Market Buys
$908K
Open-Market Sells
$0
Net Open-Market Flow
$908K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 12, 2025Buy(S)40K$22.70$908K231K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001161697-25-000374) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.